GA
SYNH

Geneva Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Geneva Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-247,121
Closed -$11.3M – 802
2017
Q1 		$11.3M Sell
247,121
-1,142
-0.5% -$56.8K 0.2% 91
2016
Q4 		$13.1M Buy
248,263
+242,178
+3,980% +$11.7M 0.25% 83
2016
Q3 		$271K Buy
+6,085
New +$264K 0.01% 599

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geneva Advisors's SYNH Position: Q2 2017 in Review

Geneva Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2017, closing a stake of 247,121 shares — an estimated $11.3M sold.

Geneva Advisors first reported a position in SYNH in Q3 2016 and held it in 3 quarters. The position peaked at $13.1M in Q4 2016. 247 funds tracked by Wall St. Rank hold SYNH as of Q2 2017.

  • Geneva Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2017 after selling out during the quarter.
  • Geneva Advisors sold 247,121 Syneos Health, Inc. Class A Common Stock shares in Q2 2017, an estimated $11.3M.
  • Geneva Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 3 quarters.
  • Geneva Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $13.1M in Q4 2016.
  • 247 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.